Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Puma Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.

Get PBYI alerts

About Douglas Hunt

The proxy statement of Puma Biotechnology, Inc. reports total compensation of $1,061,400 for Douglas Hunt in fiscal 2025, including a base salary of $489,060. Disclosed compensation is on record for 8 fiscal years. Puma Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Puma Biotechnology, Inc. includes Alan Auerbach (CEO and Board Member), Alan H. Auerbach (CEO and Board Member), Maximo Nougues (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Puma Biotechnology, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Puma Biotechnology, Inc. (PBYI) $489,060 $1,061,400
2024 Puma Biotechnology, Inc. (PBYI) $461,892 $1,217,501
2023 Puma Biotechnology, Inc. (PBYI) $428,026 $1,021,553
2022 Puma Biotechnology, Inc. (PBYI) $398,164 $738,381
2021 Puma Biotechnology, Inc. (PBYI) $379,204 $983,962
2020 Puma Biotechnology, Inc. (PBYI) $364,619 $1,593,974
2019 Puma Biotechnology, Inc. (PBYI) $350,595 $1,378,837
2018 Puma Biotechnology, Inc. (PBYI) $329,690 $6,754,592

Recent activity

No call appearances or filed executive changes recorded yet.